Thrombospondin-2 inhibits tumor cell invasion through the modulation of MMP-9 and uPA in pancreatic cancer cells

Molecular Medicine Reports

Volumn 1, Issue 3, 2008, Pages 423-427

  Nakamura, Masato ^a,c,d   Oida, Yasuhisa ^a,c   Abe, Yoshiyuki ^b,c   Yamazaki, Hitoshi ^c   Mukai, Masaya ^a   Matsuyama, Masahiro ^c   Chijiwa, Tsuyoshi ^c   Matsumoto, Hozumi ^c   Ueyama, Yoshito ^c,d  

^a TOKAI UNIVERSITY HACHIOJI HOSPITAL   (Japan)

^b Tokorozawa PET Diagnostic Imaging Clinic   (Japan)

^c TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

Author keywords

Invasion; Matrix metalloproteinase 9; Pancreatic cancer; Thrombospondin 2; Urokinase type plasminogen activator

Indexed keywords

GELATINASE B; MATRIX METALLOPROTEINASE; PLASMIN; PLASMINOGEN; THROMBOSPONDIN 1; THROMBOSPONDIN 2; UROKINASE;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELL INVASION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; PANCREAS CANCER; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; ZYMOGRAPHY;

EID: 64549120691     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.1.3.423     Document Type: Article

References (29)

1. Murr MM, Sarr MG, Oishi AJ and van Heerden JA: Pancreatic cancer. CA Cancer J Clin 44: 304-318, 1994.
2. Iwamura T, Katuski T and Ide K: Establishment and characterization of a human pancreatic cacer cell line (SUIT-2) producing carcinoembryonic antigen and carbohydrate antigen 19-9. Jpn J Cancer Res 78: 54-62, 1987. (Pubitemid 17037867)
3. Volpert OV, Tolsma SS, Pellerin S, Feige JJ, Chen H, Mosher DF and Bouck N: Inhibition of angiogenesis by thrombospondin-2. Biochem Biophys Res Commun 217: 326-332, 1995.
4. Streit M, Riccardi L, Velasco P, Brown LF, Hawighorst T, Bornstein P and Detmar M: Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis. Proc Natl Acad Sci USA 96: 14888-14893, 1999. (Pubitemid 30019735)
5. Kyriakides TR, Zhu YH, Yang Z and Bornstein P: The distribution of the matricellular protein thrombospondin 2 in tissues of embryonic and adult mice. J Histochem Cytochem 46: 1007-1015, 1998. (Pubitemid 28402481)
6. Iruela-Arispe ML, Bornstein P and Sage H: Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc Natl Acad Sci USA 88: 5026-5030, 1991. (Pubitemid 21914676)
7. Weinstat-Saslow DL, Zabrenetzky VS, van Houtte K, Frazier WA, Roberts DD and Steeg PS: Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res 54: 6504-6511, 1994.
8. Good DJ, Polverini PJ, Rastinejad F, Le Beau MM, Lemons RS, Frazier WA and Bouck NP: A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA 87: 6624-6628, 1990. (Pubitemid 20351533)
9. Lawler J: The functions of thrombospondin-1 and -2. Curr Opin Cell Biol 12: 634-640, 2000.
10. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31, 1995.
11. Tolsma SS, Volpert OV, Good DJ, Frazier WA, Polverini PJ and Bouck N: Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J Cell Biol 122: 497-511, 1993. (Pubitemid 23210475)
12. Bornstein P: Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J Cell Biol 130: 503-506, 1995.
13. Streit M, Velasco P, Brown LF, Skobe M, Richard L, Riccardi L, Lawler J and Detmar M: Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas. Am J Pathol 155: 441-452, 1999. (Pubitemid 29370394)
14. Rofstad EK and Graff BA: Thrombospondin-1-mediated metastasis suppression by the primary tumor in human melanoma xenografts. J Invest Dermatol 117: 1042-1049, 2001. (Pubitemid 34205896)
15. Liotta LA: Tumor invasion and metastasis - role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res 46: 1-7, 1986.
16. Murphy G and Garantilovic J: Proteolysis and cell migration: creating a path? Curr Opin Cell Biol 11: 614-621, 1999.
17. Kamochi J, Tokunaga T, Tomii Y, Abe Y, Hatanaka H, Kijima H, Yamazaki H, Watanabe N, Matsuzaki S, Ueyama Y and Nakamura M: Overexpression of the thrombospondin 2 (TSP2) gene modulated by the matrix metalloproteinase family expression and production in human colon carcinoma cell line. Oncol Rep 10: 881-884, 2003.
18. Tomii Y, Kamochi J, Yamazaki H, Sawa N, Tokunaga T, Ohnishi Y, Kijima H, Ueyama Y, Tamaoki N and Nakamura M: Human thrombospondin 2 inhibits proliferation of microvascular endothelial cells. Int J Oncol 20: 339-342, 2002.
19. Abe Y, Nakamura M, Ohnishi Y, Inaba M, Ueyama Y and Tamaoki N: Multidrug resistance gene (MDR1) expression in human tumor xenografts. Int J Oncol 5: 1285-1292, 1994. (Pubitemid 24357472)
20. Abe Y, Ohnishi Y, Yoshimura M, Ota E, Ozeki Y, Oshika Y, Tokunaga T, Yamazaki H, Ueyema Y, Ogata T, Tamaoki N and Nakamura M: P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo. Br J Cancer 74: 1929-1934, 1996.
21. Hamamoto A, Abe Y, Nishi M, Fujimori S, Ohnishi Y, Yamazaki H, Oida Y, Miyazaki N, Inada K, Ueyama Y, Iwasaki M, Inoue H and Nakamura M: Aberrant expression of the gastric mucin MUC6 in human pulmonary adenocarcinoma xenografts. Int J Oncol 26: 891-896, 2005.
22. Oida Y, Gopalan B, Miyahara R, Inoue S, Branch CD, Mhashilkar AM, Lin E, Beckele BN, Roth JA, Chada S and Ramesh R: Sulindac enhances adenoviral transfer expressing mda7/IL-24-mediated apoptosis in human lung cancer. Mol Cancer Ther 4: 291-304, 2005. (Pubitemid 40340208)
23. Hanzawa M, Shindoh M, Higashino F, Yasuda M, Inoue N, Hida K, Ono M, Kohgo T, Nakamura M, Notani K, Fukuda H, Totsuka Y, Yoshida K and Fujinaga K: Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma cell invasion by activating matrix metalloproteinase genes. Carcinogenesis 21: 1079-1085, 2000. (Pubitemid 30389331)
24. Andreasen PA, Egelund R and Petersen HH: The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci 57: 25-40, 2000. (Pubitemid 30105328)
25. Neurath H: Evolution of proteolytic enzymes. Science 224: 350-357, 1984.
26. Mignatti P and Rifkin DB: Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73: 161-195, 1993. (Pubitemid 23065437)
27. Nelson AR, Fin gleton B, Rothenberg ML and Matrisian LM: Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 18: 1135-1149, 2000.
28. Bein K and Simons M: Thrombospondin type 1 repeats interact with matrix metalloproteinase 2. Regulation of metalloproteinase activity. J Biol Chem 275: 32167-32173, 2000. (Pubitemid 30782107)
29. Qian X, Rothman VL, Nicosia RF and Tuszynski GP: Expression of thrombospondin-1 in human pancreatic adenocarcinomas: role in matrix metalloproteinase-9 production. Pathol Oncol Res 7: 251-259, 2001. (Pubitemid 34174690)